Qiagen NV - Company Profile
Powered by
All the data and insights you need on Qiagen NV in one report.
- Save hours of research time and resources with
our up-to-date Qiagen NV Strategy Report
- Understand Qiagen NV position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Qiagen NV (Qiagen) provides molecular testing solutions including instruments, consumables and automation systems to molecular diagnostics, applied testing, pharma and academia markets worldwide. It provides solutions to more than 500,000 customers across the world. The company operates through two product categories: Consumables and Related Revenue; and Instrumentation.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Focuses on the development of sample and assay technologies in molecular diagnostics, applied testing, pharma and academia markets to meet the needs of healthcare professionals and scientists. It aims to create new systems for automation of workflows, expand assays to detect and measure biomarkers for genetic identification; and integrate digital solutions with the testing process to interpret and transform raw molecular data into useful insights. In FY2022, Qiagen spent US$189.8 million on its R&D activities, which as a percentage of revenue stood at 8.2%. It has research and production facilities in the US, Germany, China, and the UK. As of December 2022, the company owned 260 issued patents in Germany, 314 issued patents in the US, and 1,776 issued patents in other major industrialized countries; and 370 pending patent applications.
Product Categories
Overview
It offers sample and assay kits, and bioinformatics solutions to extract and purify molecules from biological samples for analysis and interpretation. Key sample technologies include nucleic stabilization and purification kits for primary sample materials; kits and components for purification of nucleic acids and proteins from gel, plasmid DNA, and proteins; and molecular biology reagents. Key assay technologies include assays, kits, reagents and controls for identification and analysis of sequence-specific targets; and enzymatics consumables. Key next-generation sequencing (NGS) solutions include Ingenuity variant analysis, clinical insight, CLC genomics workbench, forensics sample collection consumables and GeneGlobe web-based portal. Views product innovation as a critical factor for the growth of the category.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Provides instrumentation systems, which automate the use of consumables into efficient workflows to perform polymerase chain reaction, next-generation sequencing and other techniques. The company’s instruments enable laboratories to perform nucleic acid sample preparation, assay setup, target detection, and interpretation of genomic information tasks. Key products include QIAcube robotic workstation for automated purification of DNA, RNA, or proteins; QIAsymphony family of instruments; QIAxcel; QIAstat-Dx, QIAcuity, QIAgility compact benchtop instruments; NeuMoDx and PyroMark. Key services include installation, training and other instrumentation services. Views partnerships and product innovation are the critical growth drivers for the category.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer